Skip to content

Checked

Class IIIDrug recallTerminated

Nicotine Gum recall

Recalled by P & L Developments, LLC of Westbury, NY · FDA report 10/07/2020

Not an official recall notice and may be delayed. Confirm with the manufacturer or the agency.

Class
Class III
Low risk
Status
Terminated
Closed 01/21/2022
Recall started
09/09/2020
Distribution
Nationwide

Reason for recall

Labeling: Incorrect or Missing Package Insert: The package insert included in the finished product is for the Canadian market and is not part of the current approved drug labeling.

Class III: Use of or exposure to the product is not likely to cause adverse health consequences.

Recalled product

Product
Nicotine Gum, Nicotine Polacrilex Gum USP, 2 mg (nicotine), 110-count pieces per carton, Distributed By: Rite Aid, 30 Hunter Lane, Camp Hill, PA 17011, NDC 11822-3328-3.
Lot and code info
Lot # WJ04186, exp. date 01/23
Quantity
4,752 cartons
Recall number
D-0004-2021
Event ID
86403
Initiated by
Voluntary: Firm initiated

Where it was distributed

Recalled product was distributed to one retailer type in NY and MD who may have further distributed the product throughout the United States.

Recall timeline

  1. 09/09/2020Firm started the recall
  2. 10/01/2020FDA classified it as Class III
  3. 10/07/2020Published in the FDA enforcement report
  4. 01/21/2022FDA closed (terminated) the recall

More recalls from P & L Developments

Frequently asked questions

Why was Nicotine Gum recalled?
Labeling: Incorrect or Missing Package Insert: The package insert included in the finished product is for the Canadian market and is not part of the current approved drug labeling.
What does Class III mean?
Class III is FDA's low risk recall category: use of or exposure to the product is not likely to cause adverse health consequences.
Where was the recalled product sold?
Recalled product was distributed to one retailer type in NY and MD who may have further distributed the product throughout the United States.
Is this recall still active?
The FDA lists the recall as terminated (closed 01/21/2022). FDA has determined the recall is complete and closed it.

Source: U.S. Food and Drug Administration, openFDA enforcement report · Last updated 10/07/2020 · Do not rely on openFDA to make decisions regarding medical care